Thanks, Rod!
With regards to share price, I have also come to the conclusion that the shorts and the traders are controlling most of the share price fluctuation, neither of which have really figured out, or don’t really care (the more likely scenario) about the real potential of rHuPH20 being a universal delivery platform. The good news is that time will run out for the shorts when they cannot find any more shares to short. This is when the market (SP) will shift in favor of the longs (simple supply & demand).
As an FYI, Roche is holding a conference on Monday. While there is no evidence of a Halozyme mention, it is worth paying attention to.
Good Luck,
Siri
Market Data 
Markets 
AI
